Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours
Conditions: Endometrial Cancer; Gastric Cancer; Metastatic Castration-resistant Prostate Cancer; Ovarian Cancer; Colorectal Cancer Interventions: Drug: Datopotamab deruxtecan (Dato-DXd); Drug: AZD5305; Drug: Durvalumab; Drug: Capecitabine; Drug: 5-Fluorouracil; Drug: Nivolumab; Drug: Carboplatin; Drug: Leucovorin LV; Drug: Bevacizumab Sponsors: AstraZeneca; Daiichi Sankyo, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: AstraZeneca | Avastin | Cancer | Cancer & Oncology | Gastroenterology | Research | Study | Xeloda